RNA biomarkers for alcohol use disorder

Area of Science:

• Biomarkers
• Systems Biology
• Artificial Intelligence

Background:

• Alcohol use disorder (AUD) is a prevalent global health issue with limited diagnostic sensitivity and specificity in current biomarkers.
• Existing AUD treatments lack objective molecular markers for patient stratification and predicting treatment response.
• Personalized medicine approaches are needed to optimize interventions for the heterogeneous AUD population.

Purpose of the Study:

• To review the application of transcriptomic data and AI in developing molecular biomarkers for AUD.
• To explore the potential of these biomarkers in improving diagnosis, patient stratification, and treatment selection.
• To discuss future directions for utilizing systems biology approaches in AUD management.

Main Methods:

• Review of current research on transcriptomic data and AI in AUD biomarker discovery.
• Analysis of systems biology approaches for integrating multi-omic data.
• Discussion of the role of artificial intelligence in analyzing complex biological networks.

Main Results:

• Transcriptomic data combined with AI offers potential for sensitive and specific molecular biomarkers for AUD.
• Objective biomarkers can enable precise patient stratification and prediction of treatment response.
• Systems biology approaches can capture complex genetic and environmental interactions in AUD.

Conclusions:

• Transcriptomic and AI-driven biomarkers represent a significant advancement for personalized AUD treatment.
• Objective molecular markers are crucial for improving clinical management, treatment development, and patient outcomes in AUD.
• Future research should focus on validating and integrating these advanced biomarker strategies into clinical practice.